Nan Shan Life Insurance Co. Ltd. Purchases 92,048 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Nan Shan Life Insurance Co. Ltd. boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 133.4% during the 4th quarter, Holdings Channel reports. The fund owned 161,048 shares of the semiconductor company’s stock after buying an additional 92,048 shares during the period. Nan Shan Life Insurance Co. Ltd.’s holdings in Synopsys were worth $41,750,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in SNPS. ARK Investment Management LLC boosted its holdings in Synopsys by 568.2% in the third quarter. ARK Investment Management LLC now owns 631,126 shares of the semiconductor company’s stock worth $135,048,000 after acquiring an additional 536,678 shares in the last quarter. Ninety One UK Ltd boosted its holdings in Synopsys by 118.3% in the fourth quarter. Ninety One UK Ltd now owns 958,168 shares of the semiconductor company’s stock worth $248,395,000 after acquiring an additional 519,161 shares in the last quarter. Nuveen Asset Management LLC boosted its holdings in Synopsys by 21.9% in the third quarter. Nuveen Asset Management LLC now owns 2,363,573 shares of the semiconductor company’s stock worth $505,757,000 after acquiring an additional 424,781 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Synopsys by 21.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,794,400 shares of the semiconductor company’s stock worth $383,965,000 after acquiring an additional 315,099 shares in the last quarter. Finally, Alkeon Capital Management LLC boosted its holdings in Synopsys by 12.8% in the third quarter. Alkeon Capital Management LLC now owns 2,689,809 shares of the semiconductor company’s stock worth $575,565,000 after acquiring an additional 305,000 shares in the last quarter. Institutional investors and hedge funds own 86.11% of the company’s stock.

Shares of SNPS traded down $4.08 on Tuesday, reaching $250.61. 50,063 shares of the company’s stock traded hands, compared to its average volume of 737,047. The company has a current ratio of 1.19, a quick ratio of 1.10 and a debt-to-equity ratio of 0.02. The stock has a market cap of $38.35 billion, a PE ratio of 59.79, a PEG ratio of 5.07 and a beta of 1.10. The stock’s 50 day simple moving average is $268.10 and its two-hundred day simple moving average is $233.88. Synopsys, Inc. has a 52-week low of $104.90 and a 52-week high of $300.91.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, February 17th. The semiconductor company reported $1.52 EPS for the quarter, beating the Zacks’ consensus estimate of $1.07 by $0.45. Synopsys had a return on equity of 14.81% and a net margin of 18.03%. During the same quarter in the prior year, the business earned $1.01 earnings per share. Analysts forecast that Synopsys, Inc. will post 4.41 earnings per share for the current year.

In other Synopsys news, CEO Chi-Foon Chan sold 6,372 shares of the firm’s stock in a transaction on Friday, February 19th. The stock was sold at an average price of $269.37, for a total value of $1,716,425.64. Also, Director Janice Chaffin sold 7,111 shares of the firm’s stock in a transaction on Friday, February 19th. The stock was sold at an average price of $269.38, for a total value of $1,915,561.18. Insiders have sold 38,946 shares of company stock valued at $10,045,490 over the last ninety days. 1.84% of the stock is currently owned by company insiders.

SNPS has been the subject of several analyst reports. DA Davidson increased their price objective on Synopsys from $285.00 to $335.00 and gave the stock a “buy” rating in a research note on Thursday, February 18th. UBS Group increased their price objective on Synopsys from $260.00 to $330.00 and gave the stock a “buy” rating in a research note on Tuesday, February 16th. Bank of America downgraded Synopsys from a “buy” rating to a “neutral” rating in a research note on Monday, January 11th. Needham & Company LLC increased their price objective on Synopsys from $275.00 to $310.00 and gave the stock a “buy” rating in a research note on Thursday, February 18th. Finally, Credit Suisse Group increased their price objective on Synopsys from $265.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 18th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have issued a buy rating to the stock. Synopsys presently has a consensus rating of “Buy” and an average target price of $279.33.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More: Can individual investors take part in an IPO?

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.